Planned hematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukemia and persistent SARS-CoV-2 infection

Transfusion. 2021 May;61(5):1657-1659. doi: 10.1111/trf.16361. Epub 2021 Mar 25.

Authors

Daniela Cuzzubbo¹, Francesco Pegoraro^{1

2}, Stefano Frenos¹, Tommaso Casini¹, Luisa Galli^{2

3}, Eleonora Gambineri^{1

2}, Franco Bambi⁴, Veronica Tintori¹, Claudio Favre¹

Affiliations

¹ Pediatric Haematology/Oncology and HSCT Department, Meyer Children's University Hospital, Florence, Italy.
² Department of Health Science, University of Florence, Florence, Italy.
³ Pediatric Infectious Diseases Division, Meyer Children's University Hospital, Florence, Italy.
⁴ Blood Bank, Meyer Children's University Hospital, Florence, Italy.

No abstract available

Keywords: AML; COVID-19; HSCT; SARS-CoV-2; transplantation.

Publication types

Case Reports
Letter

MeSH terms

COVID-19* / blood
COVID-19* / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Leukemia, Myeloid, Acute* / blood
Leukemia, Myeloid, Acute* / therapy
Male
SARS-CoV-2 / metabolism*
Transplantation Conditioning*
Transplantation, Homologous